Relationship between Finnish diabetes risk score and metabolic syndrome, vitamin d and insulin resistance in women

The  Finnish  Diabetes  Risk  Score  (FINDRISC)  is  thought  to  be  associated  with cardiovascular  risk  factors  separately  from  type  2  diabetes.  We  aimed  to  evaluate  the  relationship between FINDRISC and metabolic syndrome, vitamin D and insulin resistance in this study.

115  women  were  recruited  to  study.  Patients  were  divided  into  5  groups  according  to FINDRISC score. Metabolic syndrome was assessed in patients with FINDRISC scores, body mass index (BMI), fasting blood glucose (FBG), HbA1c, insulin resistance index (HOMA-IR), high density lipoprotein cholesterol (HDL), triglyceride (TG), systolic and diastolic hypertension.

Relationship between Finnish diabetes risk score and metabolic syndrome, vitamin d and insulin resistance in women

Metabolic syndrome (MS) is one of the most important causes leading to atherosclerotic vascular diseases and type 2 diabetes (Type 2 DM). The main components of metabolic syndrome are abdominal obesity, insulin resistance, increased blood pressure and lipid disorders. The frequency of the metabolic syndrome varies with increasing age and body weight, as well as with communities examined at the same time. In the United States, the incidence of metabolic syndrome is 27%, and the incidence of metabolic syndrome is increasing faster in women. In Turkey, the prevalence of metabolic syndrome is 38%. Metabolic syndrome is a combination of metabolic risk factors for cardiovascular diseases as well as insulin resistance. Recently, a simple, fast, non-invasive and practical screening tool has been developed to describe the high risk of future type 2 diabetes development in individuals.